Uncategorized
Tuttle Capital Pushes Boundaries With TRUMP And MELANIA Memecoin ETFs, Along With Few Others
Tuttle Capital Management filed for 10 leveraged crypto ETFs, including 2x exposure to XRP, Solana, Litecoin, and more. If approved, these could start trading by April and signal a new era for crypto ETFs. read more
Synchrony Financial Q4: Earnings Miss, Lower Purchase Volume, Active Accounts Decline And More
Synchrony Financial reported Q4 results with a Y/Y increase in net interest income, driven by higher interest and fees on loans. Net revenue and average accounts declined, while deposit growth and capital return to shareholders were positive. read more
10 Analysts Have This To Say About UnitedHealth Group
Latest Ratings for UNH Date Firm Action From To Jan 2022 SVB Leerink Maintains Outperform Jan 2022 BMO Capital Maintains Market Perform Jan 2022 Raymond James Maintains Strong Buy View More Analyst Ratings for UNH View the Latest Analyst Ratings read more
Assessing Stag Industrial: Insights From 4 Financial Analysts
Latest Ratings for STAG Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Jan 2022 Baird Downgrades Outperform Neutral Jan 2022 Raymond James Maintains Outperform View More Analyst Ratings for STAG View the Latest Analyst Ratings read more
Assessing Bank of Hawaii: Insights From 4 Financial Analysts
Latest Ratings for BOH Date Firm Action From To Oct 2021 Jefferies Maintains Hold Oct 2020 Piper Sandler Maintains Neutral Apr 2020 Compass Point Upgrades Neutral Buy View More Analyst Ratings for BOH View the Latest Analyst Ratings read more
A Glimpse Into The Expert Outlook On Vanda Pharma Through 4 Analysts
Latest Ratings for VNDA Date Firm Action From To Feb 2022 Jefferies Downgrades Buy Hold May 2021 B of A Securities Initiates Coverage On Buy Jan 2021 Citigroup Downgrades Buy Neutral View More Analyst Ratings for VNDA View the Latest Analyst Ratings read more
Deep Dive Into Bristol-Myers Squibb Stock: Analyst Perspectives (9 Ratings)
Latest Ratings for BMY Date Firm Action From To Mar 2022 Wells Fargo Maintains Equal-Weight Dec 2021 Goldman Sachs Initiates Coverage On Buy Dec 2021 Wells Fargo Initiates Coverage On Equal-Weight View More Analyst Ratings for BMY View the Latest Analyst Ratings read more
Analyst Expectations For Amgen’s Future
Latest Ratings for AMGN Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Wells Fargo Maintains Equal-Weight Feb 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for AMGN View the Latest Analyst Ratings read more
Assessing Eli Lilly: Insights From 7 Financial Analysts
Latest Ratings for LLY Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 Mizuho Maintains Buy Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for LLY View the Latest Analyst Ratings read more
Beyond The Numbers: 18 Analysts Discuss Regeneron Pharmaceuticals Stock
Latest Ratings for REGN Date Firm Action From To Feb 2022 Truist Securities Maintains Buy Feb 2022 Oppenheimer Maintains Outperform Feb 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for REGN View the Latest Analyst Ratings read more